TheLancetsets extremely high standards. We select only the best research papers for their quality of work and the progression they bring.
Apr 8, 2026 ·Explore original research, reviews, opinion, and news from TheLancetInfectious Diseases, covering international issues relevant to clinical infectious diseases specialists worldwide
Driven by human-caused greenhouse gas emissions, climate change is increasingly claiming lives and harming people's health worldwide. Mean annual temperatures exceeded 1·5°C above those of pre-industrial times for the first time in 2024. Despite ever more urgent calls to tackle climate change, greenhouse gas emissions rose to record levels that same year. Climate change is increasingly ...
As we can see from the illustration, Lancet Cgm Sensor Selection has many fascinating aspects to explore.
Feb 28, 2026 ·In his first speech as Secretary of the US Department of Health and Human Services (HHS), Robert F Kennedy Jr laid out a plan to restore trust. The COVID-19 pandemic saw public faith in Federal health and science plummet—between April, 2020, and September, 2023, the percentage of polling respondents who trusted coronavirus and vaccine information from the Centers for Disease Control and ...
Moving forward, it's essential to keep these visual contexts in mind when discussing Lancet Cgm Sensor Selection.
Jun 14, 2025 ·IRF progression-free survival and overall survival were longer in the lurbinectedin plus atezolizumab group than the atezolizumab group for patients with ES-SCLC, albeit with a higher incidence of adverse events. Lurbinectedin plus atezolizumab represents a novel therapeutic option for first-line maintenance treatment in this setting.
